Title : Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension.

Pub. Date : 2015 Sep 24

PMID : 26291199






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension. selexipag prostaglandin I2 receptor Homo sapiens